ClinicalTrials.govpublic full text
Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection
hepatocellular carcinoma (hcc), hcc, vetc, recurrence, pd-1, lenvatinib, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889656
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.